Your browser doesn't support javascript.
The role of comorbidities on mortality of COVID-19 in patients with diabetes.
Emami, Amir; Akbari, Ali; Basirat, Atefeh; Zare, Hamid; Javanmardi, Fatemeh; Falahati, Farshad; Rezaei, AliAkbar.
  • Emami A; Microbiology Department, Burn & Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Akbari A; Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Basirat A; Health System Research Department, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Zare H; Traditional Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Javanmardi F; Microbiology Department, Burn & Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Falahati F; Health System Research Department, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Rezaei A; Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Obes Med ; 25: 100352, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1230694
ABSTRACT

BACKGROUND:

Patients with diabetes are one of the most high-risk group to become infected with SARS-CoV-2. Current study was designed to evaluate the risk of other complications in COVID-19 patients with diabetes.

METHODS:

In this cross-sectional study (25 February to July 10, 2020), 458 patients with diabetes were enrolled based on their characteristics, symptoms and signs, laboratory data and presence of other underlying diseases. Multiple logistic regression and Chi-square test analysis were used to check the effectiveness of other comorbidities on the mortality outcome among patients with diabetes.

RESULTS:

Of 458 patients with diabetes, 306 (67%) had other underlying diseases, such as 200 (65.4%) hypertension, 103 (33.7%) cardiovascular diseases and 29 (9.5%) kidney diseases. The rate of fatality was significantly high in patients with chronic kidney and liver diseases. The odds of mortality were increased 3.1-fold for patients over 55 years as compared to those under 55 years (P = 0.011), and the odds of mortality outcome were more than 5.1-fold for those who had chronic kidney disease (P < 0.001).

CONCLUSIONS:

The presentation of SARS-CoV-2 in older patients with diabetes with other comorbidities such as chronic kidney and liver diseases is more severe in risk of mortality.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Obes Med Year: 2021 Document Type: Article Affiliation country: J.obmed.2021.100352

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Obes Med Year: 2021 Document Type: Article Affiliation country: J.obmed.2021.100352